期刊文献+

冠心病心脏运动康复的心血管保护机制及临床获益研究进展 被引量:17

Research advances on cardiovascular protection mechanism and clinical benefits of cardiac rehabilitation in coronary heart disease
下载PDF
导出
摘要 近年来,随着心脏康复(cardiac rehabilitation,CR)的发展冠心病预后及不良心血管事件得以改善,但以运动为基础的心脏康复干预冠心病心血管保护机制仍未明确。微小核糖核酸(microRNA,miRNAs)是一类内源性的非编码RNA,参与基因转录后表达调控。越来越多研究表明,运动调节心脏及循环中的miRNAs产生心血管保护作用,这进一步验证miRNAs是心血管疾病治疗的潜在靶点,并为评估运动有效性提供潜在生物标志物。本文就近年来运动的心血管保护机制、运动调节miRNAs产生的心血管作用及冠心病实施CR的临床获益做一综述,为研究及治疗冠心病提供新思路。 In recent years,with the development of Cardiac Rehabilitation(CR),the prognosis of coronary heart disease and adverse cardiovascular events have improved,but the cardiovascular protection mechanism for coronary heart disease intervention based on exercise-based cardiac rehabilitation remains unclear. MicroRNAs(miRNAs)are a class of endogenous non-coding RNAs that participate in the regulation of gene expression after transcription. More and more studies show that exercise regulates the cardiovascular effects of miRNAs in the heart and circulation,which further validates miRNAs as potential targets for cardiovascular disease treatment and provides potential biomarkers for assessing the effectiveness of exercise. In this article,the cardiovascular protection mechanisms of exercise in recent years,the cardiovascular effects of exercise-regulated miRNAs,and the clinical benefits of CR are discussed,aiming to provide new ideas for theresearch and treatment of coronary heart disease.
作者 周叶珍 蒋慧 曾肖娜 马国添 ZHOU Yezhen;JIANG Hui;ZENG Xiaona;MA Guotian(Department of Cardiolo gy,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China;不详)
出处 《实用医学杂志》 CAS 北大核心 2020年第8期1000-1004,共5页 The Journal of Practical Medicine
基金 2019年度广西医疗卫生适宜技术开发与推广应用项目(编号:S2019008) 2018年度广西卫计委资助课题(编号:Z20181040)。
关键词 心脏康复 运动 冠心病 MICRORNAS cardiac rehabilitation exercise coronary heart disease microRNAs
  • 相关文献

参考文献3

二级参考文献32

  • 1张坚,满青青,王春荣,李红,由悦,翟屹,李莹,赵文华.中国18岁及以上人群血脂水平及分布特征[J].中华预防医学杂志,2005,39(5):302-305. 被引量:112
  • 2姚崇华,胡以松,翟凤英,杨晓光,孔灵芝,中国居民营养与健康状况调查技术执行组.我国2002年代谢综合征的流行情况[J].中国糖尿病杂志,2007,15(6):332-335. 被引量:135
  • 3MAHALLE N, GARG M, KULKARNI M, et al. Association of inflammatory cytokines with traditional and nontraditional cardiovascular risk factors in indians with known coronary artery disease [J]. Ann Med Health Sci Res, 2014,4(5): 706-712.
  • 4CAGNIN S, BISCUOLA M, PATUZZO C, et al. Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries [J]. BMC genomics, 2009,10: 13.
  • 5PRAJAPATI J, JAIN S, VIRPARIYA K, et al. Novel atherosclerotic risk factors and angiographic profile of young Gujarati patients with acute coronary syndrome [J]. J Assoc Physicians India, 2014,62(7) :584-588.
  • 6CHENGJM, OEMRAWSINGH RM, GARCIA-GARCIA HM, et al. Relation of C-reactive protein to coronary plaque characteristics on grayscale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris (from the ATHEROREMO-IVUS study) [J]. Am J Cardiol, 2014, 114( 10) : 1497-1503.
  • 7PISCHON T, GIRMAN CJ, SACKS FM, et al. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men [J]. Circulation, 2005,112(22) : 3375-3383.
  • 8DI ANGELANTONIO E, SARW AR N, PERRY P, et al. Major lipids, apolipoproteins, and risk of vascular disease [J]. JAMA, 2009,302(18):1993-2000.
  • 9CESARI M, PENNINX BW, NEWMAN AB, et al. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study) [J]. Am J Cardiol , 2003,92(5):522-528.
  • 10LUC G, ARVEILER D, EVANS A, et al. Circulating soluble adhesion molecules ICAM-l and VCAM-l and incident coronary heart disease: the PRIME Study [J]. Atherosclerosis, 2003, 170(1) : 169-176.

共引文献3471

同被引文献171

引证文献17

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部